Director Nash bought 10,000 BBWI shares at $15.58; stock -58.9% from 52-week high, 5 other insiders buying concurrently.
Director Sarah E Nash purchased 10,000 shares at $15.58 on 2025-11-24, bringing her holdings to 285,522 shares (+3.6% net change). The transaction occurs as Bath & Body Works trades at $16.90, down 58.9% from its 52-week high of $41.08 and down 46.4% over the past 90 days. The company's fundamentals show annual revenue growth of -1.6% and a low P/E of 4.96, though it generated $77.0M in net income on $1.6B quarterly revenue. Notably, this buy is part of a cluster pattern: 5 other insiders also purchased shares within the past 14 days, suggesting coordinated confidence at depressed valuations. Nash's own cross-ticker trading record shows strong execution on sell timing (100% well-timed rate on prior sells with -30.3% average 90-day return), and her prior BBWI trade in June 2024 was similarly well-timed, adding credibility to her current accumulation decision amid significant price deterioration.
Director Nash Sarah E sold 48,000 BBWI shares at $41.50 on 2024-06-18 for $1,992,120.00, reducing holdings by 24.3%.
Director Sarah E Nash sold 48,000 shares representing a 24.3% reduction in her holdings, executed at $41.50 while the stock has since declined 18.6% from its 52-week high of $51.94. The company shows declining annual revenue growth at -1.7% year-over-year and a tight P/E of 10.96, suggesting modest growth expectations embedded in the current valuation. The sale's timing relative to recent stock momentum (down 15.4% over 30 days and 9.5% over 90 days) provides no clear directional signal about management's forward outlook, but the substantial reduction in a director's position stake merits investor attention given the company's modest profitability ($87.0M net income on $1.4B quarterly revenue) and market conditions.
